Southeast Asian stocks, hit particularly hard by the shutdown of tourism and other service industries, are making a comeback as optimism grows over a return to travel.
The MSCI Asean Index has surged 14% in an eight-day winning streak, almost double the 7.4% rally in the MSCI Asia Pacific Index over the same period. At its highest since March, the gauge of Southeast Asian shares has narrowed the gap with its peers but still remains down about 14% for the year. The broader Asian gauge is up 8%.
Investors are jumping on Southeast Asian stocks as part of a global rotation intovalue and out of growth sectors after positive results from a Pfizer Inc. vaccine boosted sentiment. Governments across the region are looking to ease social distancing measures, with Singapore and Hong Kongannouncing Wednesday they will start an air travel bubble replacing quarantine with Covid-19 testing from Nov. 22.
“The vaccine news opens up sectors under great stress like airlines and hotels,” Leon Goldfeld, head of multi-asset solutions for Asia Pacific at JPMorgan Asset Management, said in a press briefing Wednesday, speaking about the wider trend. “What we’ve seen is a massive rotation in the market from growth to value.”
The value rotation will likely last three to six months and has “some room to run,” he added.
The “stars are aligning” for a resurgence in Southeast Asian stocks, amid signs that earnings have bottomed out, according to Devendra Joshi, a strategist at HSBC Holdings Plc. The bank is overweight shares from Indonesia, Singapore and Thailand.
“Activity in Asean has picked up considerably since the trough, as indicated by manufacturing PMIs and mobility,” Joshi wrote in a Tuesday note. With about a third of companies having reported earnings so far, 60% have met or exceeded expectations, a higher proportion than the first two quarters of the year, he said.
The Thai market, hit especially hard due to the downturn in tourism and the widespread protests over the monarchy, is starting to attract interest from overseas investors again.
Foreign buyers piled a net more than $600 million into Thai stocks on Tuesday, thebiggest purchase in 10 years, as the benchmark SET Index jumped the most since April.
Analysts at Credit Suisse Group AG have raised theirrating for Thai stocks to overweight, thanks to progress on the coronavirus vaccine.
For UBS Group AG strategist Niall MacLeod, Southeast Asian stocks are finally reacting to the potential for a vaccine, after missing out on past rallies on the theme. That increases the possibility that at the very least they can outperform larger peers like China.
“It might still be too early to call for a rotation where Southeast Asia leads the overall market,” he wrote in a note with colleagues Wednesday. “Nevertheless, the relative valuation and outperformance year-to-date suggest China and Taiwan could underperform the region on better vaccine news and broader opening up of the global economy.”
— With assistance by Moxy Ying
Source: Read Full Article